Financials

  • Market Capitalization 8.16 B
  • Employee 691
  • Founded 2014
  • CEO Rich Adcock
  • Website www.immunitybio.com
  • Headquarter Delaware, United States
  • FIGI BBG007T9DYW9
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-5.21
Fiyat/satışlar oranı
16.08

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
1012
APGE
Apogee Therapeutics, Inc. - Common Stock
133.82 USD+0.13%+0.25%+49.25%+149.71%8.28 B USD
1016
PCVX
Vaxcyte, Inc. - Common Stock
57.03 USD-2.03%-1.30%+19.53%+34.82%8.23 B USD
1026
SYRE
Spyre Therapeutics, Inc. - Common Stock
93.73 USD-4.10%+5.46%+14.91%+292.01%8.14 B USD
1041
IMVT
Immunovant, Inc. - Common Stock
38.70 USD-2.54%-0.77%+14.50%+101.46%7.95 B USD

Haberler